Supplementary Figure 1 from Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers

Abstract
Supplementary Figure 1: Kaplan-Meier plots depicting progression free survival (PFS) for patients with advanced biliary tract cancer as a function of pretreatment biomarker levels divided into tertiles: